| Year |
Citation |
Score |
| 2019 |
Zhu Z, Mesci P, Bernatchez JA, Gimple RC, Wang X, Schafer ST, Wettersten HI, Beck S, Clark AE, Wu Q, Prager BC, Kim LJY, Dhanwani R, Sharma S, Garancher A, ... Weis SM, et al. Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin αβ Axis. Cell Stem Cell. PMID 31956038 DOI: 10.1016/J.Stem.2019.11.016 |
0.335 |
|
| 2019 |
Wettersten HI, Weis SM, Pathria P, von Schalscha T, Minami T, Varner JA, Cheresh DA. Arming tumor-associated macrophages to reverse epithelial cancer progression. Cancer Research. PMID 31416839 DOI: 10.1158/0008-5472.Can-19-1246 |
0.424 |
|
| 2017 |
Cosset É, Ilmjärv S, Dutoit V, Elliott K, von Schalscha T, Camargo MF, Reiss A, Moroishi T, Seguin L, Gomez G, Moo JS, Preynat-Seauve O, Krause KH, Chneiweiss H, Sarkaria JN, ... ... Weis SM, et al. Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma. Cancer Cell. 32: 856-868.e5. PMID 29198914 DOI: 10.1016/J.Ccell.2017.10.016 |
0.382 |
|
| 2017 |
Seguin L, Camargo MF, Wettersten HI, Kato S, Desgrosellier JS, von Schalscha T, Elliott KC, Cosset E, Lesperance J, Weis SM, Cheresh DA. Galectin-3, a druggable vulnerability for KRAS-addicted cancers. Cancer Discovery. PMID 28893801 DOI: 10.1158/2159-8290.Cd-17-0539 |
0.408 |
|
| 2017 |
Wettersten HI, Minami T, Kaneda MM, Seguin L, Varner JA, Weis SM, Cheresh DA. Abstract 3966: Targeting integrin αvβ3-expressing cancer stem cells to manipulate tumor-associated macrophages Cancer Research. 77: 3966-3966. DOI: 10.1158/1538-7445.Am2017-3966 |
0.388 |
|
| 2017 |
Seguin L, Camargo MF, Wettersten HI, Kato S, Schalscha Tv, Elliott KC, Weis SM, Cheresh DA. Abstract 3067: Galectin-3, a target for KRAS-addicted lung cancer Cancer Research. 77: 3067-3067. DOI: 10.1158/1538-7445.Am2017-3067 |
0.365 |
|
| 2016 |
Wilson R, Espinosa-Diez C, Kanner N, Chatterjee N, Ruhl R, Hipfinger C, Advani SJ, Li J, Khan OF, Franovic A, Weis SM, Kumar S, Coussens LM, Anderson DG, Chen CC, et al. MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment. Nature Communications. 7: 13597. PMID 27886180 DOI: 10.1038/Ncomms13597 |
0.35 |
|
| 2016 |
Chen C, Wilson R, Kanner N, Espinosa-Diez C, Advani S, Li J, Khan O, Franovic A, Weis S, Anderson D, Cheresh D, Anand S. ANGI-09. microRNA INHIBITION OF ENDOTHELIAL DNA REPAIR CAPACITY AS A GLIOBLASTOMA THERAPEUTIC STRATEGY Neuro-Oncology. 18: vi16-vi17. DOI: 10.1093/Neuonc/Now212.064 |
0.317 |
|
| 2015 |
Advani SJ, Camargo MF, Seguin L, Mielgo A, Anand S, Hicks AM, Aguilera J, Franovic A, Weis SM, Cheresh DA. Kinase-independent role for CRAF-driving tumour radioresistance via CHK2. Nature Communications. 6: 8154. PMID 26333361 DOI: 10.1038/Ncomms9154 |
0.312 |
|
| 2015 |
Franovic A, Elliott KC, Seguin L, Camargo MF, Weis SM, Cheresh DA. Glioblastomas Require Integrin αvβ3/PAK4 Signaling to Escape Senescence. Cancer Research. 75: 4466-73. PMID 26297735 DOI: 10.1158/0008-5472.Can-15-0988 |
0.43 |
|
| 2015 |
Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends in Cell Biology. 25: 234-40. PMID 25572304 DOI: 10.1016/J.Tcb.2014.12.006 |
0.421 |
|
| 2015 |
Jean C, Chen XL, Tancioni I, Uryu S, Lawson C, Miller N, Turowski P, Dejana E, Weis S, Cheresh D, Schlaepfer DD. Abstract A04: Endothelial FAK activity controls vascular permeability and tumor metastasis Cancer Research. 75. DOI: 10.1158/1538-7445.Chtme14-A04 |
0.488 |
|
| 2014 |
Seguin L, Gozo M, Weis SM, Cheresh DA. Targeting the Achilles' heel of drug-resistant cancer stem cells. Cell Cycle (Georgetown, Tex.). 13: 2017-8. PMID 24906000 DOI: 10.4161/Cc.29460 |
0.436 |
|
| 2014 |
Seguin L, Weis SM, Cheresh DA. Variety in the tumor microenvironment: integrin splicing regulates stemness. Cell Stem Cell. 14: 557-8. PMID 24792112 DOI: 10.1016/J.Stem.2014.04.011 |
0.405 |
|
| 2014 |
Seguin L, Kato S, Franovic A, Camargo MF, Lesperance J, Elliott KC, Yebra M, Mielgo A, Lowy AM, Husain H, Cascone T, Diao L, Wang J, Wistuba II, Heymach JV, ... ... Weis SM, et al. An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. Nature Cell Biology. 16: 457-68. PMID 24747441 DOI: 10.1038/Ncb2953 |
0.345 |
|
| 2014 |
Jean C, Chen XL, Nam JO, Tancioni I, Uryu S, Lawson C, Ward KK, Walsh CT, Miller NL, Ghassemian M, Turowski P, Dejana E, Weis S, Cheresh DA, Schlaepfer DD. Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function. The Journal of Cell Biology. 204: 247-63. PMID 24446483 DOI: 10.1083/Jcb.201307067 |
0.482 |
|
| 2014 |
Kato S, Seguin L, Franovic A, Kato H, Camargo M, Desgrosellier J, Anand S, Weis S, Shattil S, Cheresh DA. Abstract 4240: Targeting Galectin-3 to reverse tumor stemness and drug resistance Cancer Research. 74: 4240-4240. DOI: 10.1158/1538-7445.Am2014-4240 |
0.385 |
|
| 2014 |
Seguin LJ, Kato S, Franovic A, Camargo MF, Elliott K, Yebra M, Lesperance J, Mielgo A, Desgrosellier J, Anand S, Weis S, Cheresh D. Abstract 1916: β3 integrin/KRAS/RalB complex drives tumor stemness and resistance to EGFR inhibition Cancer Research. 74: 1916-1916. DOI: 10.1158/1538-7445.Am2014-1916 |
0.412 |
|
| 2013 |
Weis SM, Cheresh DA. A wake-up call for hibernating tumour cells. Nature Cell Biology. 15: 721-3. PMID 23817234 DOI: 10.1038/Ncb2794 |
0.331 |
|
| 2013 |
Jean C, Nam J, Chen X, Uryu S, Tancioni I, Lawson C, Ward KK, Walsh CT, Ghassemian M, Turowski P, Dejana E, Weis SM, Cheresh DA, Schlaepfer DD. Abstract B39: Inhibiting endothelial FAK activity blocks tumor cell extravasation Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-B39 |
0.508 |
|
| 2012 |
Lim ST, Miller NL, Chen XL, Tancioni I, Walsh CT, Lawson C, Uryu S, Weis SM, Cheresh DA, Schlaepfer DD. Nuclear-localized focal adhesion kinase regulates inflammatory VCAM-1 expression. The Journal of Cell Biology. 197: 907-19. PMID 22734001 DOI: 10.1083/Jcb.201109067 |
0.369 |
|
| 2012 |
Lau SK, Shields DJ, Murphy EA, Desgrosellier JS, Anand S, Huang M, Kato S, Lim ST, Weis SM, Stupack DG, Schlaepfer DD, Cheresh DA. EGFR-mediated carcinoma cell metastasis mediated by integrin αvβ5 depends on activation of c-Src and cleavage of MUC1. Plos One. 7: e36753. PMID 22586492 DOI: 10.1371/Journal.Pone.0036753 |
0.394 |
|
| 2012 |
Chen XL, Nam JO, Jean C, Lawson C, Walsh CT, Goka E, Lim ST, Tomar A, Tancioni I, Uryu S, Guan JL, Acevedo LM, Weis SM, Cheresh DA, Schlaepfer DD. VEGF-induced vascular permeability is mediated by FAK. Developmental Cell. 22: 146-57. PMID 22264731 DOI: 10.1016/J.Devcel.2011.11.002 |
0.439 |
|
| 2012 |
Scheppke L, Murphy EA, Zarpellon A, Hofmann JJ, Merkulova A, Shields DJ, Weis SM, Byzova TV, Ruggeri ZM, Iruela-Arispe ML, Cheresh DA. Notch promotes vascular maturation by inducing integrin-mediated smooth muscle cell adhesion to the endothelial basement membrane. Blood. 119: 2149-58. PMID 22134168 DOI: 10.1182/Blood-2011-04-348706 |
0.396 |
|
| 2012 |
Seguin LJ, Mielgo A, Huang M, Camargo FC, Lesperance J, Weis SM, Desgrosellier JS, Cheresh DA. Abstract LB-344: Emergence of carcinoma resistance to EGFR blockade via an integrin avb3/RalB/NFkB signaling axis Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-344 |
0.404 |
|
| 2011 |
Weis SM, Cheresh DA. αV integrins in angiogenesis and cancer. Cold Spring Harbor Perspectives in Medicine. 1: a006478. PMID 22229119 DOI: 10.1101/Cshperspect.A006478 |
0.467 |
|
| 2011 |
Mielgo A, Seguin L, Huang M, Camargo MF, Anand S, Franovic A, Weis SM, Advani SJ, Murphy EA, Cheresh DA. A MEK-independent role for CRAF in mitosis and tumor progression. Nature Medicine. 17: 1641-5. PMID 22081024 DOI: 10.1038/Nm.2464 |
0.416 |
|
| 2011 |
Weis SM, Cheresh DA. Tumor angiogenesis: molecular pathways and therapeutic targets. Nature Medicine. 17: 1359-70. PMID 22064426 DOI: 10.1038/Nm.2537 |
0.415 |
|
| 2011 |
Weis SM. Evaluation of VEGF-induced vascular permeability in mice. Methods in Molecular Biology (Clifton, N.J.). 763: 403-15. PMID 21874467 DOI: 10.1007/978-1-61779-191-8_27 |
0.451 |
|
| 2011 |
Aspinall RJ, Weis SM, Barnes L, Lutu-Fuga K, Bylund DJ, Pockros PJ, Cheresh DA. A Src family kinase inhibitor improves survival in experimental acute liver failure associated with elevated cerebral and circulating vascular endothelial growth factor levels. Liver International : Official Journal of the International Association For the Study of the Liver. 31: 1222-30. PMID 21745297 DOI: 10.1111/J.1478-3231.2011.02554.X |
0.386 |
|
| 2011 |
Mielgo A, Murphy E, Huang M, Seguin L, Weis S, Cheresh D. Abstract 2919: Unexpected role of CRAF in tumor cell mitosis revealed by an allosteric inhibitor Cancer Research. 71: 2919-2919. DOI: 10.1158/1538-7445.Am2011-2919 |
0.434 |
|
| 2010 |
Anand S, Majeti BK, Acevedo LM, Murphy EA, Mukthavaram R, Scheppke L, Huang M, Shields DJ, Lindquist JN, Lapinski PE, King PD, Weis SM, Cheresh DA. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nature Medicine. 16: 909-14. PMID 20676106 DOI: 10.1038/Nm.2186 |
0.314 |
|
| 2010 |
Nam J, Acevedo LM, Goka E, Chen XL, Walsh C, Tanjoni I, Guan J, Weis SM, Cheresh DA, Schlaepfer DD. Abstract 389: Mice with kinase-dead FAK mutation in endothelial cells are protected from VEGF-induced permeability and are resistant to tumor cell metastasis Cancer Research. 70: 389-389. DOI: 10.1158/1538-7445.Am10-389 |
0.461 |
|
| 2009 |
Weis SM, Stupack DG, Cheresh DA. Agonizing integrin antagonists? Cancer Cell. 15: 359-61. PMID 19411065 DOI: 10.1016/J.Ccr.2009.04.005 |
0.333 |
|
| 2008 |
Weis SM. Chapter 5. Evaluating vascular leak in vivo. Methods in Enzymology. 444: 99-114. PMID 19007662 DOI: 10.1016/S0076-6879(08)02805-X |
0.365 |
|
| 2008 |
Murphy EA, Majeti BK, Barnes LA, Makale M, Weis SM, Lutu-Fuga K, Wrasidlo W, Cheresh DA. Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proceedings of the National Academy of Sciences of the United States of America. 105: 9343-8. PMID 18607000 DOI: 10.1073/Pnas.0803728105 |
0.347 |
|
| 2008 |
Scheppke L, Aguilar E, Gariano RF, Jacobson R, Hood J, Doukas J, Cao J, Noronha G, Yee S, Weis S, Martin MB, Soll R, Cheresh DA, Friedlander M. Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits. The Journal of Clinical Investigation. 118: 2337-46. PMID 18483622 DOI: 10.1172/Jci33361 |
0.41 |
|
| 2008 |
Acevedo LM, Weis SM, Cheresh DA. Robo4 counteracts VEGF signaling. Nature Medicine. 14: 372-3. PMID 18391935 DOI: 10.1038/Nm0408-372 |
0.391 |
|
| 2008 |
Weis SM. Vascular permeability in cardiovascular disease and cancer. Current Opinion in Hematology. 15: 243-9. PMID 18391792 DOI: 10.1097/Moh.0B013E3282F97D86 |
0.421 |
|
| 2008 |
Weis SM, Lim ST, Lutu-Fuga KM, Barnes LA, Chen XL, Göthert JR, Shen TL, Guan JL, Schlaepfer DD, Cheresh DA. Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK. The Journal of Cell Biology. 181: 43-50. PMID 18391070 DOI: 10.1083/Jcb.200710038 |
0.432 |
|
| 2008 |
Acevedo LM, Barillas S, Weis SM, Göthert JR, Cheresh DA. Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood. 111: 2674-80. PMID 18180379 DOI: 10.1182/Blood-2007-08-110205 |
0.426 |
|
| 2007 |
Weis SM. Evaluating integrin function in models of angiogenesis and vascular permeability. Methods in Enzymology. 426: 505-28. PMID 17697897 DOI: 10.1016/S0076-6879(07)26021-5 |
0.419 |
|
| 2007 |
Weis SM, Lindquist JN, Barnes LA, Lutu-Fuga KM, Cui J, Wood MR, Cheresh DA. Cooperation between VEGF and beta3 integrin during cardiac vascular development. Blood. 109: 1962-70. PMID 17062734 DOI: 10.1182/Blood-2005-10-038893 |
0.383 |
|
| 2006 |
Doukas J, Wrasidlo W, Noronha G, Dneprovskaia E, Fine R, Weis S, Hood J, Demaria A, Soll R, Cheresh D. Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury. Proceedings of the National Academy of Sciences of the United States of America. 103: 19866-71. PMID 17172449 DOI: 10.1073/Pnas.0606956103 |
0.359 |
|
| 2005 |
Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature. 437: 497-504. PMID 16177780 DOI: 10.1038/Nature03987 |
0.422 |
|
| 2005 |
Weis SM, Zimmerman SD, Shah M, Covell JW, Omens JH, Ross J, Dalton N, Jones Y, Reed CC, Iozzo RV, McCulloch AD. A role for decorin in the remodeling of myocardial infarction. Matrix Biology : Journal of the International Society For Matrix Biology. 24: 313-24. PMID 15949932 DOI: 10.1016/J.Matbio.2005.05.003 |
0.438 |
|
| 2004 |
Weis S, Cui J, Barnes L, Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. The Journal of Cell Biology. 167: 223-9. PMID 15504909 DOI: 10.1083/Jcb.200408130 |
0.397 |
|
| 2004 |
Weis S, Shintani S, Weber A, Kirchmair R, Wood M, Cravens A, McSharry H, Iwakura A, Yoon YS, Himes N, Burstein D, Doukas J, Soll R, Losordo D, Cheresh D. Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. The Journal of Clinical Investigation. 113: 885-94. PMID 15067321 DOI: 10.1172/Jci20702 |
0.32 |
|
| 2001 |
Gregersen H, Weis SM, McCulloch AD. Oesophageal morphometry and residual strain in a mouse model of osteogenesis imperfecta. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 13: 457-64. PMID 11696107 DOI: 10.1046/J.1365-2982.2001.00279.X |
0.438 |
|
| 2000 |
Weis SM, Emery JL, Becker KD, McBride DJ, Omens JH, McCulloch AD. Myocardial mechanics and collagen structure in the osteogenesis imperfecta murine (oim). Circulation Research. 87: 663-9. PMID 11029401 DOI: 10.1161/01.Res.87.8.663 |
0.438 |
|
| Show low-probability matches. |